Transactions With Shares and Linked Securities in Genmab AS Made by Managerial Employees and Their Closely Associated Persons

GMAB Stock  USD 21.30  0.38  1.82%   
About 57% of all Genmab AS's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Genmab AS suggests that some traders are interested. The current market sentiment, together with Genmab AS's historical and current headlines, can help investors time the market. In addition, many technical investors use Genmab AS stock news signals to limit their universe of possible portfolio assets.
  
Company Announcement COPENHAGEN, Denmark December 3, 2024 Genmab AS In accordance with Article 19 of Regulation No. 5962014 on Market Abuse and Implementing Regulation 2016523, this document discloses the data of the transactions made in Genmab AS made by managerial employees and their closely associated persons. The companys managerial employees and their closely associated persons have given Genmab AS power of attorney on their behalf to publish trading

Read at finance.yahoo.com
Yahoo News
  

Genmab AS Current Investor Sentiment

Comfort Level 57

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Genmab AS's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Genmab AS.
57.0%
66.0%
50.0%

Genmab AS Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Genmab AS can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Genmab AS Historical Investor Sentiment

Investor biases related to Genmab AS's public news can be used to forecast risks associated with an investment in Genmab. The trend in average sentiment can be used to explain how an investor holding Genmab can time the market purely based on public headlines and social activities around Genmab AS. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
News FrequencyInvestor Sentiment
Genmab AS's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Genmab AS and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Genmab AS news discussions. The higher the estimate score, the more favorable the investor's outlook on Genmab AS.

Genmab AS Fundamental Analysis

We analyze Genmab AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genmab AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genmab AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Genmab AS is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Genmab AS Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genmab AS stock to make a market-neutral strategy. Peer analysis of Genmab AS could also be used in its relative valuation, which is a method of valuing Genmab AS by comparing valuation metrics with similar companies.

Peers

Genmab AS Related Equities

CYTKCytokinetics   10.91   
0%
100.0%
AMLXAmylyx Pharmaceuticals   3.62   
0%
33.0%
AKROAkero Therapeutics   2.62   
0%
24.0%
ALECAlector   1.80   
0%
16.0%
DAWNDay One   0.41   
0%
3.0%
PCVXVaxcyte   0.19   
0%
1.0%
LEGNLegend Biotech   0.08   
0%
1.0%
ASNDAscendis Pharma   0.00   
0%
0%
APLSApellis Pharmaceuticals   0.22   
2.0%
0%
TERNTerns Pharmaceuticals   0.49   
4.0%
0%
BPMCBlueprint Medicines   1.31   
12.0%
0%
EWTXEdgewise Therapeutics   2.42   
22.0%
0%
TVTXTravere Therapeutics   3.41   
31.0%
0%

Complementary Tools for Genmab Stock analysis

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators